| Q34717923 | Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses |
| Q34995659 | Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease |
| Q35446144 | Clinical aspects of Marburg hemorrhagic fever |
| Q33826885 | Different potential of C-type lectin-mediated entry between Marburg virus strains |
| Q35790316 | Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure |
| Q34664182 | Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation |
| Q33677571 | Evidence for retrovirus and paramyxovirus infection of multiple bat species in china |
| Q36395831 | Forty-five years of Marburg virus research |
| Q34484140 | Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation |
| Q34476404 | Hapten mediated display and pairing of recombinant antibodies accelerates assay assembly for biothreat countermeasures |
| Q22305521 | Intracellular events and cell fate in filovirus infection |
| Q30204337 | Mapping the zoonotic niche of Marburg virus disease in Africa |
| Q40433085 | Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. |
| Q28385386 | Neurological Complications of Ebola Virus Infection |
| Q35882397 | Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. |
| Q36404178 | Potential vaccines and post-exposure treatments for filovirus infections |
| Q36382884 | Reasons for the increase in emerging and re-emerging viral infectious diseases |
| Q34301750 | Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30 |
| Q34289541 | Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo |
| Q35077488 | Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains |
| Q37384496 | Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report |
| Q38914892 | Short communication: a cluster of Marburg virus disease involving an infant |
| Q34699060 | The emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts. |
| Q40039066 | The lifecycle of the Ebola virus in host cells |
| Q37157191 | The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus |
| Q33918317 | The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola |
| Q33195339 | Tropical dermatology: viral tropical diseases |
| Q42371906 | Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies |
| Q27485491 | Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections |